Skip to Main Content

Author Details

Saghar Kaabinejadian
Pure MHC LLC
2010
14
9
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37085710Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome.Commun Biol2023
38000035Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning.Sci Adv2023
35154160Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome.Front Immunol2022
36314681Subcellular location of source proteins improves prediction of neoantigens for immunotherapy.EMBO J2022
36253002Localized ablative immunotherapy drives de novo CD8<sup>+</sup> T-cell responses to poorly immunogenic tumors.J Immunother Cancer2022
32308001Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.J Proteome Res2020
31685621Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.Proc Natl Acad Sci U S A2019
29107334MHC-I Genotype Restricts the Oncogenic Mutational Landscape.Cell2017
26719579Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.Mol Cancer Ther2016
27183642Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.J Immunol2016
25837513Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.Science2015
24723377A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.Eur J Immunol2014
23762485Identification of class I HLA T cell control epitopes for West Nile virus.PLoS One2013
22615588Molecular analysis of MEN1 expression in MCF7, T47D and MDA-MB 468 breast cancer cell lines treated with adriamycin using RT-PCR and immunocytochemistry.Daru2010
  • 1 - 14 of 14

Recommended Authors

Mary A Wood
Phase Genomics Inc.
Career Start Year 2018
Number of shared co-authors 0
Paisley T Myers
Agenus Inc.
Career Start Year 2017
Number of shared co-authors 1
Pavlo A Nesterenko
Oregon Health and Science University
Career Start Year 2016
Number of shared co-authors 0
Scott D Brown
BC Cancer Research Institute
Career Start Year 2014
Number of shared co-authors 0
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 1
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 1
Santiago J Carmona
AGORA Cancer Research Center
Career Start Year 2008
Number of shared co-authors 0
Ilka Hoof
LEO Pharma
Career Start Year 2007
Number of shared co-authors 2
Daniel Rivera
Center for Natural Products Research, University of Havana
Career Start Year 2005
Number of shared co-authors 0
Christopher Szeto
La Trobe Institute for Molecular Science, La Trobe University
Career Start Year 2005
Number of shared co-authors 0
David S DeLuca
Hannover Medical School
Career Start Year 2004
Number of shared co-authors 1
Junbao Yang
Benaroya Research Institute
Career Start Year 2003
Number of shared co-authors 0
Suchit Jhunjhunwala
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Julie A McMurry
University of Colorado - Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 2
Florence A Castelli
Universite Paris Saclay
Career Start Year 2002
Number of shared co-authors 0
William D Martin
EpiVax Inc.
Career Start Year 2001
Number of shared co-authors 0
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 0
Randi Vita
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Career Start Year 1995
Number of shared co-authors 2
Leonard Moise
EpiVax Inc.
Career Start Year 1991
Number of shared co-authors 0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0
Anne S De Groot
University of Georgia
Career Start Year 1989
Number of shared co-authors 0
Anthony W Purcell
Monash Biomedicine Discovery Institute, Monash University
Career Start Year 1989
Number of shared co-authors 2
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Career Start Year 1984
Number of shared co-authors 4
William W Kwok
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1982
Number of shared co-authors 1
Victor H Engelhard
University of Virginia School of Medicine
Career Start Year 1976
Number of shared co-authors 0
Gerald T Nepom
Wash Benaroya Research Institute at Virginia Mason
Career Start Year 1975
Number of shared co-authors 0
S??ren Buus
University of Copenhagen
Career Start Year 1974
Number of shared co-authors 2
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 0

Collaborators

William H Hildebrand
University of Oklahoma Health Sciences Center
Co-authored papers 12
Carolina Barra
Co-authored papers 3
Michael S Diamond
Washington University School of Medicine
Co-authored papers 2
Elaine R Mardis
The Ohio State University
Co-authored papers 2
Ted H Hansen
Co-authored papers 2
Vincent Magrini
The Ohio State University
Co-authored papers 2
Jasreet Hundal
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 2
Bjoern Peters
University of Washington School of Medicine
Co-authored papers 2
Hannah Carter
University of California San Diego
Co-authored papers 2
Rachel Marty Pyke
University of California San Diego
Co-authored papers 1
David H Spencer
Washington University School of Medicine.
Co-authored papers 1
Michael Slifker
Fox Chase Cancer Center
Co-authored papers 1
Malachi Griffith
Washington University
Co-authored papers 1
Mark M Davis
Co-authored papers 1
Obi L Griffith
Washington University
Co-authored papers 1
David Rossell
Universitat Pompeu Fabra
Co-authored papers 1
Hatice Billur Engin
University of California
Co-authored papers 1
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Co-authored papers 1
Joan Font-Burgada
Fox Chase Cancer Center
Co-authored papers 1
Joris van de Haar
the Netherlands Cancer Institute, University of California
Co-authored papers 1
Nicola de Prisco
Columbia University Irving Medical Center
Co-authored papers 1
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 1
Release 1.2